Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Oral Cavity Carcinoma: early-phase trial registry

3 of 5 indexed Oral Cavity Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Oral Cavity Carcinoma: 5 US clinical trials tracked, 3 recruiting.

Oral Cavity Carcinoma is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Masonic Cancer Center, University of Minnesota, running 1 of these trials.

Enrollment posture brief

Registry condition oral-cavity-carcinoma

OPEN 3 | RECR 60% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Oral Cavity Carcinoma (this)60%
Open-enrollment share among volume-matched conditions near Oral Cavity Carcinoma

Oral Cavity Carcinoma lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Oral Cavity Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Oral Cavity Carcinoma is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Oral Cavity Carcinoma research.

    Masonic Cancer Center, University of Minnesota accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Oral Cavity Carcinoma enrolment sits around 119 participants.

    Median target enrolment is 119 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Oral Cavity Carcinoma research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23

Phase Distribution

PhaseTrial count
Phase 2 3

Named interventions

Most-linked intervention names on Oral Cavity Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Medical Device Usage and Evaluation Other
2 trials
Questionnaire Administration Other
2 trials
Consultation Other
1 trials
Intensity-Modulated Proton Therapy Procedure
1 trials
Metformin Hydrochloride Drug
1 trials
Breath Test Procedure
1 trials
Alcohol Drug
1 trials
Behavioral Intervention Behavioral
1 trials

US sites by state

Facility locations filed on Oral Cavity Carcinoma trials. A trial with sites in several states counts in each.

Minnesota 3 trials
Florida 2 trials
Arizona 2 trials
Wisconsin 1 trials
Texas 1 trials
Pennsylvania 1 trials
New Jersey 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Oral Cavity Carcinoma page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Oral Cavity Carcinoma condition card totals 5 registered trials; most-linked intervention Medical Device Usage and Evaluation; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.